Jeremy Beitler
CUIMC/Milstein Hospital Building
Office
177 Ft. Washington Avenue
New York, NY 10032
About
ARDS occurs in up to one-quarter of all critically ill adults receiving mechanical ventilation. Despite considerable advances in understanding of disease pathogenesis, ARDS remains associated with high risk of death—up to 45% mortality for severe disease. The most effective proven therapy for ARDS is to limit the degree of lung stretch with each machine-supported breath. Yet, how best to personalize ventilatory support to each individual patient';s unique risk of lung injury is unclear. Dr. Beitler';s research seeks to address this gap by advancing understanding of the interaction between pulmonary biomechanics and lung biology. He uses advanced techniques such as esophageal manometry, electrical impedance tomography, and airway waveform analysis to quantify lung mechanics at bedside. These measures are paired with biological samples to identify dose-response between lung stretch and biological injury.
Dr. Beitler would like to express his gratitude to the many patients and families who have advanced this research by participating in clinical studies. He sincerely believes your essential support ultimately will help improve survival and decrease morbidity for patients suffering from acute respiratory failure.
Jeremy Beitler
Dr. Jeremy Beitler is a pulmonary intensivist and Director of Clinical Research for the Center for Acute Respiratory Failure at Columbia University. Clinically, he cares for patients admitted to the medical intensive care units (MICUs) at New York-Presbyterian Hospital / Columbia University Medical Center. His NIH-funded research program focuses on optimizing mechanical ventilatory support for patients with acute respiratory failure, including acute respiratory distress syndrome (ARDS).ARDS occurs in up to one-quarter of all critically ill adults receiving mechanical ventilation. Despite considerable advances in understanding of disease pathogenesis, ARDS remains associated with high risk of death—up to 45% mortality for severe disease. The most effective proven therapy for ARDS is to limit the degree of lung stretch with each machine-supported breath. Yet, how best to personalize ventilatory support to each individual patient';s unique risk of lung injury is unclear. Dr. Beitler';s research seeks to address this gap by advancing understanding of the interaction between pulmonary biomechanics and lung biology. He uses advanced techniques such as esophageal manometry, electrical impedance tomography, and airway waveform analysis to quantify lung mechanics at bedside. These measures are paired with biological samples to identify dose-response between lung stretch and biological injury.
Dr. Beitler would like to express his gratitude to the many patients and families who have advanced this research by participating in clinical studies. He sincerely believes your essential support ultimately will help improve survival and decrease morbidity for patients suffering from acute respiratory failure.
Primary Specialty
Critical Care Surgeon
Practice
CUIMC/Milstein Hospital Building
Gender
Male
Not Accepting New Patients
Insurances Accepted
UnitedHealthcare, Magnacare (National), Medicare, Local 1199, Multiplan, RiverSpring, Emblem/Hip, CIGNA, Emblem/GHI
Degrees
Medical Doctor, Master of Public Health
Office Name
CUIMC/Milstein Hospital Building
Services
Jeremy Beitler provides critical care surgery in New York, NY. A Critical Care Surgeon, acute care, emergency medicine, surgery, surgeon, respiratory failure, shock, renal failure, sepsis, life-threatening illness, ICU, intensive care.
Please call CUIMC/Milstein Hospital Building at to schedule an appointment in New York, NY or get more information. Additional Services Surgeon, Doctor
Please call CUIMC/Milstein Hospital Building at to schedule an appointment in New York, NY or get more information. Additional Services Surgeon, Doctor
Consumer Feedback
Add a Review
There are no recent reviews. Be the first!
©2024 Wellness®.com is a registered trademark of Wellness.com, Inc. 